Dr. Warren Steven Brenner, MD

Dr. Brenner practices at Boca Raton Regional Hospital in Boca Raton, Florida, part of Baptist Health South Florida.

Dr. Brenner's NPI, 1003865338, was assigned on May 5, 2006. Dr. Brenner graduated from University of the Witwatersrand in 1996. Dr. Brenner holds Florida license 94685.

Dr. Brenner's primary practice is Boca Raton Regional Hospital, at 800 Meadows Rd, Boca Raton, FL 33486 in Palm Beach County. The practice phone is (561) 955-4200.

Dr. Brenner's primary practice is Boca Raton Regional Hospital in Boca Raton, Florida, part of Baptist Health South Florida. Dr. Brenner is also affiliated with Delray Medical Center. The medical group on file is Eugene M. & Christine E. Lynn Cancer Institute (Lynn Cancer Institute). Dmand AI also links Dr. Brenner to 1 more group practice or clinic, named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Brenner practices, 3 sites in all. Vendor and product names are available with a free account.

Medical oncology is Dr. Brenner's primary specialty in the NPI Registry, under taxonomy code 207RX0202X. Dr. Brenner is board certified in hematology by the American Board of Internal Medicine. Dmand AI has Dr. Brenner's licenses on file in 2 states: Florida and Missouri.

Dmand AI lists chronic anemia, chronic embolism thrombosis, chronic leukemia, colorectal cancer, immune deficiency disease, lung cancer, lymphoma and multiple myeloma among the conditions Dr. Brenner treats.

CMS data shows 3,520 Medicare services from Dr. Brenner across 9 procedure codes in 2024, for 621 Medicare patients. Medicare paid $183,556 for them.

CMS counts 621 Medicare patients who saw Dr. Brenner in 2024. The largest group is 75 to 84, with 322 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 4% are also on Medicaid. Their average risk score is 2.50, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Brenner's median patient age at 77, with 45% women.

In 2024, Dr. Brenner wrote 938 Medicare Part D claims for 192 patients. 60% of them were for generic drugs. CMS names the drug for 690 of them, across 23 drugs with 11 or more claims each, at $5,143,896 in total drug cost. In 2023, CMS named 882 claims across 32 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 75 out of 100 for Dr. Brenner for performance year 2024, reported individually. Dr. Brenner accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

Dmand AI links 3 papers to Dr. Brenner, published from 2021 to 2025. Dr. Brenner's most frequent co-authors are Lodovico Balducci, MD, Savita Bidyasar, MD and Jason K. Boyd, MD.

Dmand AI links Dr. Brenner to 5 clinical trials, 3 of them phase 3 studies. 1 is still active or recruiting. Conditions studied include Pancreatic Neoplasms, Pancreatic Diseases and Rectal Diseases. Open Payments lists research payments to Dr. Brenner that name 1 trial.

CMS Open Payments shows 554 general payments to Dr. Brenner from 43 drug and device companies from 2016 to 2025. Speaker and faculty fees make up the largest share, 57% of the total. Celgene Corporation paid the most, $174,173. It also lists 1 research payment totaling $172 in 2019, naming 1 clinical trial.

Dmand AI lists 1 award for Dr. Brenner, most recently CMS Stage 1 EHR in 2013.

Dr. Brenner graduated from University of the Witwatersrand in 1996. Dr. Brenner is a member of ASCO.

Dr. Brenner is in network with 17 carriers, including Aetna, Elevance and Excellus BlueCross BlueShield. PPO plans come from the most carriers, 12. Check the plan with the practice before a visit.